T2Biosystems Establishes Clinical Advisory Board of Leading Infectious Disease and Critical Care Experts  
5/23/2011 7:33:53 AM

T2 Biosystems, Inc., a company developing next-generation diagnostic products to improve clinical care, today announced that a panel of leading infectious disease and critical care experts have joined the company’s newly formed Clinical Advisory Board (CAB). The T2 Biosystems CAB members will help prioritize and support the development of the company’s pipeline of diagnostic products for infectious diseases and acute care conditions, including the lead development application for detection of the fungal infection Candida, using the company’s assay and magnetic biosensor nanotechnology.